GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Dividend Yield %

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Dividend Yield % : 1.69% (As of May. 19, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Dividend Yield %?

As of today (2024-05-19), the Trailing Annual Dividend Yield of Shenzhenlubris Pharmaceuticals Co is 1.69%.

The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's Dividend Yield % or its related term are showing as below:

SZSE:002294' s Dividend Yield % Range Over the Past 10 Years
Min: 0.75   Med: 1.69   Max: 4.6
Current: 1.69

During the past 13 years, the highest Dividend Yield of Shenzhenlubris Pharmaceuticals Co was 4.60%. The lowest was 0.75%. And the median was 1.69%.

SZSE:002294's Dividend Yield % is ranked worse than
54.55% of 308 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs SZSE:002294: 1.69

Shenzhenlubris Pharmaceuticals Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Salubris Pharmaceuticals Co Ltd is 0.91, which seems too high.

During the past 13 years, the highest Dividend Payout Ratio of Shenzhenlubris Pharmaceuticals Co was 125.00. The lowest was 0.37. And the median was 0.60.

As of today (2024-05-19), the Forward Dividend Yield % of Shenzhenlubris Pharmaceuticals Co is 0.00%.

Shenzhenlubris Pharmaceuticals Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Shenzhenlubris Pharmaceuticals Co's average Dividends Per Share Growth Rate was 25.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shenzhenlubris Pharmaceuticals Co was 75.50% per year. The lowest was -20.60% per year. And the median was 23.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Shenzhenlubris Pharmaceuticals Co Dividend Yield % Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Dividend Yield % Chart

Shenzhenlubris Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.01 1.76 - 1.23 1.53

Shenzhenlubris Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.60 1.69 1.53 1.72

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Dividend Yield %

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Dividend Yield % falls into.



Shenzhenlubris Pharmaceuticals Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Shenzhenlubris Pharmaceuticals Co  (SZSE:002294) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Shenzhenlubris Pharmaceuticals Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines